Compositions and methods of use for MGD-CSF in disease treatment

Details for Australian Patent Application No. 2005267062 (hide)

Owner Five Prime Therapeutics, Inc.

Inventors Behrens, Dirk; Williams, Lewis T.; Lee, Ernestine; Hestir, Kevin; Wong, Justin, G. P.; Huang, Min Mei; Marshall, Shannon; Zhou, Aileen; Bosch, Elizabeth; Linnemann, Thomas; Leo, Cindy; Wu, Ge; Doberstein, Steven; Lin, Haishan; Halenbeck, Robert Forgan

Agent Pizzeys

Pub. Number AU-B-2005267062

PCT Pub. Number WO2006/012451

Priority 60/590,565 22.07.04 US; 60/647,604 27.01.05 US; 60/664,932 24.03.05 US; 60/699,019 14.07.05 US

Filing date 21 July 2005

Wipo publication date 2 February 2006

Acceptance publication date 17 May 2012

International Classifications

C07K 14/53 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/27 (2006.01) Mutation or genetic engineering

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/012451 Priority application(s): WO2006/012451

17 May 2012 Application Accepted

  Published as AU-B-2005267062

13 September 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Aug 2012 . Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267063-A programmable particle scatterer for radiation therapy beam formation

2005267057-Method and systems for providing an infusion device interface